高转移人肝癌细胞MHCC97-H (STR)FH0095
价格：￥电议
品牌名称：富衡型号：FH0095 原产地：中国大陆 更新时间：2026/10/21 7:56:21
产品摘要：高转移人肝癌细胞；MHCC97-H 来自 1997 年收治的 61 岁男性患者的肝内门静脉转移灶，由中国团队从转移灶肿瘤组织分离建立。该细胞系通过 STR 鉴定确认为人源，且因继承了转移灶的高侵袭性特征，成为研究肝癌转移的经典模型。
支付方式：
- 支付宝 微信 银行转账
产品完善度： 访问次数：598
企业档案
会员类型：旗舰版
已获得阿仪网信誉 等级评定
61成长值
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
阿仪网旗舰版会员：3年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
参观次数：629025
详细内容
| 产品名称 | 高转移人肝癌细胞；MHCC97-H (STR) |
|---|---|
| 品牌 | FuHeng |
| 英文名 | MHCC97-H (STR) |
| 货号 | FH0095 |
| 规格 | 1×10⁶cells/T25培养瓶 |
| 价格 | 1400.0 |
| 培养 | DMEM(高糖)+10%FBS |
| 别称 | MHCC 97-H; MHCC-97H; MHCC97H |
| 形态特征 | 上皮样 |
| 生长特性 | 贴壁生长 |
| 培养条件 | 气相：空气，95%；CO2,5%温度：37℃ |
| 传代方法 | 1：2传代 |
| 组织来源 | 人肝细胞癌肝内转移灶组织 |
| 细胞简介 | 高转移人肝癌细胞；MHCC97-H 来自 1997 年收治的 61 岁男性患者的肝内门静脉转移灶，由中国团队从转移灶肿瘤组织分离建立。该细胞系通过 STR 鉴定确认为人源，且因继承了转移灶的高侵袭性特征，成为研究肝癌转移的经典模型。 |
| 特征特性 | 来源于中山医院，用人肝癌细胞株MHCC97-H接种裸鼠，进行3次肺转移筛选，取肺转移瘤建成皮下接种后高度自发性肺转移的肝癌细胞系 |
| 培养基 | MHCC97-H完全培养基 |
富衡相关文献
| 论文标题 | DOI | 发表时间 | 期刊 | 影响因子 | 作者列表 |
| RBM30 recruits DOT1L to activate STAT1 tranｓcription and drive immune evasion in hepatocellular carcinoma | 10.1038/s41388-025-03550-6 | 2025-08-29 | ONCOGENE | 7.3 | Han Hexu, Gong Chen, Zhang Yue, Liu Cuixia, Wang Yifan, Zhao Dakun, Huang Junxing, Gong Zhicheng |
| Luteolin suppresses cell migration and invasion via targeting miR-6809-5p/FLOT1/FAK and eliciting EMT in hepatocellular carcinoma | 10.1016/j.tranon.2025.102511 | 2025-08-25 | Translational Oncology | 4.1 | Pei-Wei Yang, Su-Ping Ma, Xin-Ju Chen, Fang-Ming Yang, Shou-Mei Wang, Qian Wang, Shu-Hui Zhang |
| The effect and related mechanisms of RAC1 GTP on radiotherapy for hepatocellular carcinoma | 10.21037/tcr-2025-987 | 2025-06-27 | Translational Cancer Research | 1.7 | Xiaoyu Xu, Zhengxuying Fang, Wei Jiang, Jianbo Chou, Yi Lu |
| Integrative analysis of multi-omics data identified PLG as key gene related to Anoikis resistance and immune phenotypes in hepatocellular carcinoma | 10.1186/s12967-024-05858-5 | 2024-12-04 | Journal of Translational Medicine | 6.1 | Xueyan Wang, Lei Gao, Haiyuan Li, Yanling Ma, Bofang Wang, Baohong Gu, Xuemei Li, Lin Xiang, Yuping Bai, Chenhui Ma, Hao Chen |
| Machine learning identification of NK cell immune characteristics in hepatocellular carcinoma based on single-cell sequencing and bulk RNA sequencing | 10.1007/s13258-024-01581-z | 2024-10-21 | Genes & Genomics | 1.6 | Liu Fang, Mei Baohua, Xu Jianfeng, Zou Yong, Luo Gang, Liu Haiyu |
| Repression of YEATS2 induces cellular senescence in hepatocellular carcinoma and inhibits tumor growth | 10.1080/15384101.2024.2342714 | 2024-04-15 | CELL CYCLE | 3.4 | Qi Wu, Quan Zheng, Lei Yuan, Dandan Gao, Yabing Hu, Xinqing Jiang, Qiaocheng Zhai, Ming Liu, Lifeng Xu, Heng Xu, Jinlin Ye, Feng Zhang |
| RAD21: A Key Tranｓcriptional Regulator in the Development of Residual Liver Cancer | 10.2147/JHC.S447915 | 2024-02-05 | Journal of Hepatocellular Carcinoma | 4.2 | Jin-Shu Pang, Xiu-Mei Bai, Wei-Jun Wan, Tong Kang, Rong Wen, Li-Peng Li, Hai-Hui Yin, Chun-Miao Lu, Dong-Yue Wen, Yun He, Hong Yang |
| Silibinin, a potential fasting mimetic, inhibits hepatocellular carcinoma by triggering extrinsic apoptosis | 10.1002/mco2.457 | 2024-01-11 | MedComm | 10.7 | Biying Xiao, Yanyu Jiang, Shuying Yuan, Lili Cai, Tong Xu, Lijun Jia |
| Long intergenic noncoding RNA smad7 (Linc-smad7) promotes the epithelial-mesenchymal transition of HCC by targeting the miR‑125b/SIRT6 axis | 10.1002/cam4.3515 | 2020-10-10 | Cancer Medicine | 3.491 | Lili Han, Lijun Jia, Ying Zan |
| The RNA-binding protein SORBS2 suppresses hepatocellular carcinoma tumourigenesis and ｍmbedstasis by stabilizing RORA mRNA | 10.1111/liv.14202 | 2019-07-31 | LIVER INTERNATIONAL | 5.542 | Lili Han, Chen Huang, Shuqun Zhang |
热门标签：高转移人肝癌细胞,MHCC97-H,MHCC97-H细胞
